NL8602933A - Geneesmiddel voor het behandelen van dementie. - Google Patents

Geneesmiddel voor het behandelen van dementie. Download PDF

Info

Publication number
NL8602933A
NL8602933A NL8602933A NL8602933A NL8602933A NL 8602933 A NL8602933 A NL 8602933A NL 8602933 A NL8602933 A NL 8602933A NL 8602933 A NL8602933 A NL 8602933A NL 8602933 A NL8602933 A NL 8602933A
Authority
NL
Netherlands
Prior art keywords
dementia
medicament according
medicament
acyloxyalkanoylcholine
acid residue
Prior art date
Application number
NL8602933A
Other languages
English (en)
Dutch (nl)
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NL8602933A publication Critical patent/NL8602933A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8602933A 1985-11-19 1986-11-19 Geneesmiddel voor het behandelen van dementie. NL8602933A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25788185 1985-11-19
JP60257881A JPH0733332B2 (ja) 1985-11-19 1985-11-19 痴呆症状改善・治療剤

Publications (1)

Publication Number Publication Date
NL8602933A true NL8602933A (nl) 1987-06-16

Family

ID=17312478

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8602933A NL8602933A (nl) 1985-11-19 1986-11-19 Geneesmiddel voor het behandelen van dementie.

Country Status (12)

Country Link
US (1) US4713376A (cg-RX-API-DMAC10.html)
JP (1) JPH0733332B2 (cg-RX-API-DMAC10.html)
AU (1) AU590640B2 (cg-RX-API-DMAC10.html)
CA (1) CA1278519C (cg-RX-API-DMAC10.html)
CH (1) CH668184A5 (cg-RX-API-DMAC10.html)
DE (1) DE3639378A1 (cg-RX-API-DMAC10.html)
DK (1) DK169607B1 (cg-RX-API-DMAC10.html)
FR (1) FR2590170B1 (cg-RX-API-DMAC10.html)
GB (1) GB2184653B (cg-RX-API-DMAC10.html)
IT (1) IT1200041B (cg-RX-API-DMAC10.html)
NL (1) NL8602933A (cg-RX-API-DMAC10.html)
SE (1) SE469059B (cg-RX-API-DMAC10.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
DE59900222D1 (de) * 1998-02-13 2001-10-04 Schwabe Willmar Gmbh & Co Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
WO2005019157A1 (en) * 2003-08-15 2005-03-03 Patel Hasmukh B Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
US7803842B2 (en) * 2004-06-08 2010-09-28 Hass Patel Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
BRPI0517790A (pt) * 2004-11-12 2008-10-21 Neurochem Int Ltd métodos e composições fluoradas para tratar doenças relacionadas à amilóide
CA2586334A1 (en) * 2004-11-16 2006-06-08 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
CA2592320C (en) * 2004-12-22 2015-11-24 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2007125385A2 (en) * 2005-12-22 2007-11-08 Neurochem (International) Limited Treatment of renal disorders, diabetic nephopathy and dyslipidemias
KR101443573B1 (ko) 2006-10-12 2014-11-03 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
EP2120905A1 (en) * 2006-12-22 2009-11-25 BELLUS Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
BRPI0807004A2 (pt) * 2007-02-07 2014-04-15 Argenta Discovery Ltd Sal
TW201115409A (en) * 2009-10-29 2011-05-01 Hannspree Inc A mouse capable of generating vapor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336350A (en) * 1970-12-28 1973-11-07 Toyama Chemical Co Ltd Choline derivatives and process for producing the same
DE2425983C3 (de) * 1973-06-12 1978-09-14 Toyama Chemical Co. Ltd., Tokio Sulfonsäuresalze von Acylcholinen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzung
JPS5221490A (en) * 1975-08-12 1977-02-18 Mitsubishi Rayon Co Printing method
JPS592904B2 (ja) * 1976-09-18 1984-01-21 日本ビクター株式会社 デイスプレイ装置
JPS551251A (en) * 1978-06-20 1980-01-08 Yamaha Motor Co Ltd Brake pedal for motorcycle
JPS58180463A (ja) * 1982-04-19 1983-10-21 Toyama Chem Co Ltd ビスコリンジスルホナ−ト類の製造法

Also Published As

Publication number Publication date
FR2590170A1 (fr) 1987-05-22
DE3639378C2 (cg-RX-API-DMAC10.html) 1990-05-10
FR2590170B1 (fr) 1990-08-24
DK169607B1 (da) 1994-12-27
SE8604950D0 (sv) 1986-11-19
SE8604950L (sv) 1987-05-20
GB2184653A (en) 1987-07-01
AU6530286A (en) 1987-05-21
CA1278519C (en) 1991-01-02
IT8648670A0 (it) 1986-11-19
US4713376A (en) 1987-12-15
JPS62120317A (ja) 1987-06-01
SE469059B (sv) 1993-05-10
DE3639378A1 (de) 1987-05-27
IT1200041B (it) 1989-01-05
AU590640B2 (en) 1989-11-09
GB8627484D0 (en) 1986-12-17
GB2184653B (en) 1989-11-15
JPH0733332B2 (ja) 1995-04-12
DK550586A (da) 1987-05-20
DK550586D0 (da) 1986-11-18
CH668184A5 (de) 1988-12-15

Similar Documents

Publication Publication Date Title
NL8602933A (nl) Geneesmiddel voor het behandelen van dementie.
KR0150631B1 (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
US4636494A (en) Process and composition for treating disorders by administering amphetamine and choline
HU217132B (hu) Riluzol alkalmazása AIDS-szel kapcsolatos idegi rendellenességek kezelésére alkalmas gyógyszerkészítmények előállítására
EP0437128B1 (fr) Utilisation des dérivés des fluoroquinolones pour le traitement de la pneumonie à Pneumocystis carinii
RU2341261C2 (ru) Композиции, содержащие эпотилоны, и их применение для лечения карциноидного синдрома
US4346084A (en) Process and composition for treating disorders by administering lithium and choline
KR20050119104A (ko) 치환된 퀴놀린과 치환된 디페닐설폰을 함유하는 조성물과방법
JPWO2017057562A1 (ja) 末梢神経障害又は脊髄損傷の治療剤及び/又は予防剤
JPS6124377B2 (cg-RX-API-DMAC10.html)
NL194430C (nl) Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.
WO2007113170A1 (de) Verwendung von strobilurinen zur behandlung von störungen des eisen-stoffwechsels
EP1084704B1 (en) Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia
DE69200365T2 (de) Pharmazeutische Zusammensetzung zur Verbesserung von Dysuria.
CA2064999A1 (fr) Derives de la 5-amino-1,2,3,4 tetrahydro-acridine et utilisation comme medicaments
US20040014681A1 (en) Method for treating dermatoses and tissue damage
RU2061481C1 (ru) Средство, обладающее антиагрегационной активностью
RU2601622C1 (ru) Средство, обладающее эндотелиопротекторным действием в условиях экспериментального сахарного диабета и нарушения мозгового кровообращения
EA019584B1 (ru) Холиновые соли янтарной кислоты для лечения депрессий, тревоги, шизофрении, нарушений сна и эпилепсии
US12502371B2 (en) Drug for treating and preventing dementia
KR20050108402A (ko) 만성 피부 질환의 치료제 및/또는 예방제
DE3823345A1 (de) 6-merkaptopurin-derivate, ihre herstellung und ihre verwendung zur bekaempfung von retrovirusinfektionen
WO2025152110A1 (zh) 用于阿尔兹海默症治疗的联合用药及其药物组合物
KR20240160428A (ko) 2-아미노-2-(2-(1-데실-1h-1,2,3-트라이아졸-4-일)에틸)프로판-1,3-다이올 헤미푸마르산염의 신규한 결정형 및 이를 포함하는 약학적 조성물
DE3406837A1 (de) Arteriosklerose-arzneimittel und -prophylaktikum

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable